Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
95 studies found for:    Open Studies | "Peritoneal Dialysis"
Show Display Options
Rank Status Study
21 Recruiting Natural History of Mineral Metabolism Parameters and Protein-bound Toxins in Incident Peritoneal Dialysis Patients
Condition: Complication of Peritoneal Dialysis
Intervention:
22 Not yet recruiting Peritonitis and Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients
Conditions: Loss of Residual Renal Function;   Technique Failure in Peritoneal Dialysis
Intervention:
23 Unknown  The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
Conditions: Peritoneal Dialysis;   Hemodialysis
Intervention:
24 Unknown  Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis
Condition: Peritoneal Dialysis
Intervention:
25 Unknown  Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
Conditions: Rate of Exit Site Infection;   Rate of Atypical Mycobacterial Infection;   Rate of Peritoneal Dialysis
Interventions: Drug: gentamicin;   Drug: gentamicin cream alternating with mupirocin cream
26 Not yet recruiting Effectiveness of an Online Portal for Delivery of Care to Home Dialysis Patients
Conditions: Hemodialysis, Home;   Peritoneal Dialysis
Intervention: Other: Electronic Patient Portal
27 Recruiting Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis
Condition: Peritoneal Dialysis Patients
Intervention:
28 Unknown  Biomarker for Peritoneal Ultrafiltration Failure
Condition: Continuous Ambulatory Peritoneal Dialysis
Intervention:
29 Recruiting Fosrenol and Phosphorus Balance - Lanthanum Carbonate
Conditions: Chronic Kidney Failure;   End-stage Renal Disease;   Disorders Associated With Peritoneal Dialysis
Intervention: Drug: lanthanum carbonate
30 Unknown  Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients
Conditions: Sleep Disorders;   Kidney Diseases
Intervention: Behavioral: cognitive-behavioral therapy
31 Unknown  Peritoneal Dialysis in Congestive Heart Failure
Condition: Congestive Heart Failure
Intervention: Drug: icodextrin
32 Unknown  Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
Conditions: End-Stage Renal Disease;   Renal Disease, End-Stage;   Renal Failure, End-Stage;   Obesity
Intervention:
33 Unknown  Barriers to Peritoneal Dialysis Selection
Condition: Chronic Kidney Disease
Intervention:
34 Recruiting International Pediatric Peritoneal Biopsy Study
Condition: Chronic Renal Failure (CKD 5) and Peritoneal Dialysis
Intervention: Procedure: biopsy sampling
35 Recruiting L-Cysteine in Peritoneal Dialysis
Condition: Uremia
Interventions: Dietary Supplement: L-cysteine;   Other: Placebo
36 Unknown  Probiotics Use in the Chronic Peritoneal Dialysis Patients
Conditions: Peritonitis;   Malnutrition
Interventions: Drug: Pro-biotics;   Dietary Supplement: Oligosaccharide
37 Unknown  Use of a Bimodal Solution for Peritoneal Dialysis
Condition: End Stage Renal Disease
Interventions: Drug: bimodal solution;   Drug: icodextrin
38 Recruiting Study to Determine Appropriate Nurse: Patient Ratios in Peritoneal Dialysis Programs
Condition: Chronic Renal Failure
Intervention:
39 Recruiting Residual Renal Function Preservation in Peritoneal Dialysis Patients
Condition: Chronic Renal Disease
Interventions: Drug: Losartan;   Drug: spirolactone;   Other: blank control
40 Not yet recruiting Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis
Condition: End-Stage Kidney Disease
Intervention: Drug: Ursodeoxycholic Acid

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years